-
1
-
-
42449151214
-
Functions of natural killer cells
-
DOI 10.1038/ni1582, PII NI1582
-
Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S., Functions of natural killer cells Nature Immunology 2008 9 5 503 510 (Pubitemid 351560519)
-
(2008)
Nature Immunology
, vol.9
, Issue.5
, pp. 503-510
-
-
Vivier, E.1
Tomasello, E.2
Baratin, M.3
Walzer, T.4
Ugolini, S.5
-
2
-
-
0024792513
-
Biology of natural killer cells
-
Trinchieri G., Biology of natural killer cells Advances in Immunology 1989 47 187 376 (Pubitemid 20010960)
-
(1989)
Advances in Immunology
, vol.47
, pp. 187-376
-
-
Trinchieri, G.1
-
3
-
-
0034646255
-
In vivo natural killer cell activities revealed by natural killer cell- deficient mice
-
DOI 10.1073/pnas.050588297
-
Kim S., Iizuka K., Aguila H. L., Weissman I. L., Yokoyama W. M., In vivo natural killer cell activities revealed by natural killer cell-deficient mice Proceedings of the National Academy of Sciences of the United States of America 2000 97 6 2731 2736 (Pubitemid 30159240)
-
(2000)
Proceedings of the National Academy of Sciences of the United States of America
, vol.97
, Issue.6
, pp. 2731-2736
-
-
Kim, S.1
Iizuka, K.2
Aguila, H.L.3
Weissman, I.L.4
Yokoyama, W.M.5
-
4
-
-
0036831613
-
New aspects of natural-killer-cell surveillance and therapy of cancer
-
DOI 10.1038/nrc928
-
Smyth M. J., Hayakawa Y., Takeda K., Yagita H., New aspects of natural-killer-cell surveillance and therapy of cancer Nature Reviews Cancer 2002 2 11 850 861 (Pubitemid 37328903)
-
(2002)
Nature Reviews Cancer
, vol.2
, Issue.11
, pp. 850-861
-
-
Smyth, M.J.1
Hayakawa, Y.2
Takeda, K.3
Yagita, H.4
-
5
-
-
0346749331
-
Natural Killer Cells and Cancer
-
DOI 10.1016/S0065-230X(03)90004-2
-
Wu J., Lanier L. L., Natural killer cells and cancer Advances in Cancer Research 2003 90 127 156 (Pubitemid 37549223)
-
(2003)
Advances in Cancer Research
, vol.90
, pp. 127-156
-
-
Wu, J.1
Lanier, L.L.2
-
7
-
-
0032560475
-
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
-
DOI 10.1073/pnas.95.13.7556
-
Kaplan D. H., Shankaran V., Dighe A. S., Stockert E., Aguet M., Old L. J., Schreiber R. D., Demonstration of an interferon -dependent tumor surveillance system in immunocompetent mice Proceedings of the National Academy of Sciences of the United States of America 1998 95 13 7556 7561 (Pubitemid 28293291)
-
(1998)
Proceedings of the National Academy of Sciences of the United States of America
, vol.95
, Issue.13
, pp. 7556-7561
-
-
Kaplan, D.H.1
Shankaran, V.2
Dighe, A.S.3
Stockert, E.4
Aguet, M.5
Old, L.J.6
Schreiber, R.D.7
-
8
-
-
0035953308
-
IFNγ, and lymphocytes prevent primary tumour development and shape tumour immunogenicity
-
DOI 10.1038/35074122
-
Shankaran V., Ikeda H., Bruce A. T., White J. M., Swanson P. E., Old L. J., Schreiber R. D., IFN, and lymphocytes prevent primary tumour development and shape tumour immunogenicity Nature 2001 410 6832 1107 1111 (Pubitemid 32391043)
-
(2001)
Nature
, vol.410
, Issue.6832
, pp. 1107-1111
-
-
Shankaran, V.1
Ikeda, H.2
Bruce, A.T.3
White, J.M.4
Swanson, P.E.5
Old, L.J.6
Schreiber, R.D.7
-
9
-
-
36849010167
-
Adaptive immunity maintains occult cancer in an equilibrium state
-
DOI 10.1038/nature06309, PII NATURE06309
-
Koebel C. M., Vermi W., Swann J. B., Zerafa N., Rodig S. J., Old L. J., Smyth M. J., Schreiber R. D., Adaptive immunity maintains occult cancer in an equilibrium state Nature 2007 450 7171 903 907 (Pubitemid 350231320)
-
(2007)
Nature
, vol.450
, Issue.7171
, pp. 903-907
-
-
Koebel, C.M.1
Vermi, W.2
Swann, J.B.3
Zerafa, N.4
Rodig, S.J.5
Old, L.J.6
Smyth, M.J.7
Schreiber, R.D.8
-
10
-
-
0022616253
-
Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy
-
Karre K., Ljunggren H. G., Piontek G., Kiessling R., Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy Nature 1986 319 6055 675 678 (Pubitemid 16119452)
-
(1986)
Nature
, vol.319
, Issue.6055
, pp. 675-678
-
-
Karre, K.1
Ljunggren, H.G.2
Piontek, G.3
Kiessling, R.4
-
11
-
-
0035855872
-
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
-
DOI 10.1038/35093109
-
Diefenbach A., Jensen E. R., Jamieson A. M., Raulet D. H., Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity Nature 2001 413 6852 165 171 (Pubitemid 32867877)
-
(2001)
Nature
, vol.413
, Issue.6852
, pp. 165-171
-
-
Diefenbach, A.1
Jensen, E.R.2
Jamieson, A.M.3
Raulet, D.H.4
-
12
-
-
0035949563
-
Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
-
DOI 10.1073/pnas.201238598
-
Cerwenka A., Baron J. L., Lanier L. L., Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo Proceedings of the National Academy of Sciences of the United States of America 2001 98 20 11521 11526 (Pubitemid 32928761)
-
(2001)
Proceedings of the National Academy of Sciences of the United States of America
, vol.98
, Issue.20
, pp. 11521-11526
-
-
Cerwenka, A.1
Baron, J.L.2
Lanier, L.L.3
-
13
-
-
0036143496
-
Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection
-
DOI 10.1038/ni746
-
Kelly J. M., Darcy P. K., Markby J. L., Godfrey D. I., Takeda K., Yagita H., Smyth M. J., Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection Nature Immunology 2002 3 1 83 90 (Pubitemid 34065622)
-
(2002)
Nature Immunology
, vol.3
, Issue.1
, pp. 83-90
-
-
Kelly, J.M.1
Darcy, P.K.2
Markby, J.L.3
Godfrey, D.I.4
Takeda, K.5
Yagita, H.6
Smyth, M.J.7
-
14
-
-
70249111187
-
Natural killer cells remember: An evolutionary bridge between innate and adaptive immunity?
-
Sun J. C., Lanier L. L., Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity? European Journal of Immunology 2009 39 8 2059 2064
-
(2009)
European Journal of Immunology
, vol.39
, Issue.8
, pp. 2059-2064
-
-
Sun, J.C.1
Lanier, L.L.2
-
15
-
-
12144290645
-
Innate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and γδ T Cells
-
DOI 10.1084/jem.20031981
-
Street S. E. A., Hayakawa Y., Zhan Y., Lew A. M., MacGregor D., Jamieson A. M., Diefenbach A., Yagita H., Godfrey D. I., Smyth M. J., Innate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and T Cells Journal of Experimental Medicine 2004 199 6 879 884 (Pubitemid 38375207)
-
(2004)
Journal of Experimental Medicine
, vol.199
, Issue.6
, pp. 879-884
-
-
Street, S.E.A.1
Hayakawa, Y.2
Zhan, Y.3
Lew, A.M.4
MacGregor, D.5
Jamieson, A.M.6
Diefenbach, A.7
Yagita, H.8
Godfrey, D.I.9
Smyth, M.J.10
-
16
-
-
0035874543
-
Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo
-
Koh C. Y., Blazar B. R., George T., Welniak L. A., Capitini C. M., Raziuddin A., Murphy W. J., Bennett M., Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo Blood 2001 97 10 3132 3137
-
(2001)
Blood
, vol.97
, Issue.10
, pp. 3132-3137
-
-
Koh, C.Y.1
Blazar, B.R.2
George, T.3
Welniak, L.A.4
Capitini, C.M.5
Raziuddin, A.6
Murphy, W.J.7
Bennett, M.8
-
17
-
-
33750800121
-
Human natural killer cell deficiencies
-
DOI 10.1097/ACI.0b013e3280106b65, PII 0013083220061200000002
-
Orange J. S., Human natural killer cell deficiencies Current Opinion in Allergy and Clinical Immunology 2006 6 6 399 409 (Pubitemid 44714151)
-
(2006)
Current Opinion in Allergy and Clinical Immunology
, vol.6
, Issue.6
, pp. 399-409
-
-
Orange, J.S.1
-
18
-
-
0034715948
-
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: An 11-year follow-up study of a general population
-
Imai K., Matsuyama S., Miyake S., Suga K., Nakachi K., Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population The Lancet 2000 356 9244 1795 1799
-
(2000)
The Lancet
, vol.356
, Issue.9244
, pp. 1795-1799
-
-
Imai, K.1
Matsuyama, S.2
Miyake, S.3
Suga, K.4
Nakachi, K.5
-
19
-
-
0030902366
-
The prognostic significance of intratumoral natural killer cells in patients with colerectal carcinoma
-
DOI 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0. CO;2-P
-
Coca S., Perez-Piqueras J., Martinez D., Colmenarejo A., Saez M. A., Vallejo C., Martos J. A., Moreno M., The prognostic significance of intratumoral natural killer cells in patients with colerectal carcinoma Cancer 1997 79 12 2320 2328 (Pubitemid 27251014)
-
(1997)
Cancer
, vol.79
, Issue.12
, pp. 2320-2328
-
-
Coca, S.1
Perez-Piqueras, J.2
Martinez, D.3
Colmenarejo, A.4
Saez, M.A.5
Vallejo, C.6
Martos, J.A.7
Moreno, M.8
-
20
-
-
0034141680
-
Prognostic value of intratumoral natural killer cells in gastric carcinoma
-
DOI 10.1002/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.0.CO;2- V
-
Ishigami S., Natsugoe S., Tokuda K., Nakajo A., Che X., Iwashige H., Aridome K., Hokita S., Aikou T., Prognostic value of intratumoral natural killer cells in gastric carcinoma Cancer 2000 88 3 577 583 (Pubitemid 30056932)
-
(2000)
Cancer
, vol.88
, Issue.3
, pp. 577-583
-
-
Ishigami, S.1
Natsugoe, S.2
Tokuda, K.3
Nakajo, A.4
Che, X.5
Iwashige, H.6
Aridome, K.7
Hokita, S.8
Aikou, T.9
-
21
-
-
0036136050
-
Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer
-
DOI 10.1016/S0169-5002(01)00292-6, PII S0169500201002926
-
Villegas F. R., Coca S., Villarrubia V. G., Jimnez R., Chilln M. J., Jareo J., Zuil M., Callol L., Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer Lung Cancer 2002 35 1 23 28 (Pubitemid 34028087)
-
(2002)
Lung Cancer
, vol.35
, Issue.1
, pp. 23-28
-
-
Villegas, F.R.1
Coca, S.2
Villarrubia, V.G.3
Jimenez, R.4
Chillon, M.J.5
Jareno, J.6
Zuil, M.7
Callol, L.8
-
22
-
-
0242302582
-
NK cells and the tumour microenvironment: Implications for NK-cell function and anti-tumour activity
-
DOI 10.1016/j.it.2003.09.007
-
Albertsson P. A., Basse P. H., Hokland M., Goldfarb R. H., Nagelkerke J. F., Nannmark U., Kuppen P. J. K., NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity Trends in Immunology 2003 24 11 603 609 (Pubitemid 37338529)
-
(2003)
Trends in Immunology
, vol.24
, Issue.11
, pp. 603-609
-
-
Albertsson, P.A.1
Basse, P.H.2
Hokland, M.3
Goldfarb, R.H.4
Nagelkerke, J.F.5
Nannmark, U.6
Kuppen, P.J.K.7
-
23
-
-
37549028767
-
Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer
-
Esendagli G., Bruderek K., Goldmann T., Busche A., Branscheid D., Vollmer E., Brandau S., Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer Lung Cancer 2008 59 1 32 40
-
(2008)
Lung Cancer
, vol.59
, Issue.1
, pp. 32-40
-
-
Esendagli, G.1
Bruderek, K.2
Goldmann, T.3
Busche, A.4
Branscheid, D.5
Vollmer, E.6
Brandau, S.7
-
24
-
-
0032794633
-
Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation
-
Hokland M., Kjaergaard J., Kuppen P. J. K., Nannmark U., Agger R., Hokland P., Basse P., Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48h after inoculation In Vivo 1999 13 3 199 204 (Pubitemid 29380983)
-
(1999)
In Vivo
, vol.13
, Issue.3
, pp. 199-204
-
-
Hokland, M.1
Kjaergaard, J.2
Kuppen, P.J.K.3
Nannmark, U.4
Agger, R.5
Hokland, P.6
Basse, P.7
-
25
-
-
20444394742
-
Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes
-
DOI 10.1182/blood-2004-12-4825
-
Hsu K. C., Keever-Taylor C. A., Wilton A., Pinto C., Heller G., Arkun K., O'Reilly R. J., Horowitz M. M., Dupont BO., Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes Blood 2005 105 12 4878 4884 (Pubitemid 40807317)
-
(2005)
Blood
, vol.105
, Issue.12
, pp. 4878-4884
-
-
Hsu, K.C.1
Keever-Taylor, C.A.2
Wilton, A.3
Pinto, C.4
Heller, G.5
Arkun, K.6
O'Reilly, R.J.7
Horowitz, M.M.8
Dupont, B.9
-
26
-
-
33846828702
-
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation
-
DOI 10.1097/CCO.0b013e3280148a1a, PII 0000162220070300000013
-
Ruggeri L., Mancusi A., Burchielli E., Aversa F., Martelli M. F., Velardi A., Natural killer cell alloreactivity in allogeneic hematopoietic transplantation Current Opinion in Oncology 2007 19 2 142 147 (Pubitemid 46204354)
-
(2007)
Current Opinion in Oncology
, vol.19
, Issue.2
, pp. 142-147
-
-
Ruggeri, L.1
Mancusi, A.2
Burchielli, E.3
Aversa, F.4
Martelli, M.F.5
Velardi, A.6
-
27
-
-
0036464719
-
Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγrIIIa gene
-
DOI 10.1182/blood.V99.3.754
-
Cartron G., Dacheux L., Salles G., Solal-Celigny P., Bardos P., Colombat P., Watier H., Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor Fc rIIIa gene Blood 2002 99 3 754 758 (Pubitemid 34525533)
-
(2002)
Blood
, vol.99
, Issue.3
, pp. 754-758
-
-
Cartron, G.1
Dacheux, L.2
Salles, G.3
Solal-Celigny, P.4
Bardos, P.5
Colombat, P.6
Watier, H.7
-
28
-
-
0642373290
-
Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma
-
DOI 10.1200/JCO.2003.05.013
-
Weng W. K., Levy R., Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma Journal of Clinical Oncology 2003 21 21 3940 3947 (Pubitemid 46606207)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.21
, pp. 3940-3947
-
-
Weng, W.-K.1
Levy, R.2
-
29
-
-
42949157368
-
Immunoglobulin g fragment c receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer
-
Musolino A., Naldi N., Bortesi B., Pezzuolo D., Capelletti M., Missale G., Laccabue D., Zerbini A., Camisa R., Bisagni G., Neri T. M., Ardizzoni A., Immunoglobulin g fragment c receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer Journal of Clinical Oncology 2008 26 11 1789 1796
-
(2008)
Journal of Clinical Oncology
, vol.26
, Issue.11
, pp. 1789-1796
-
-
Musolino, A.1
Naldi, N.2
Bortesi, B.3
Pezzuolo, D.4
Capelletti, M.5
Missale, G.6
Laccabue, D.7
Zerbini, A.8
Camisa, R.9
Bisagni, G.10
Neri, T.M.11
Ardizzoni, A.12
-
30
-
-
61449239114
-
Impact of fc RIIa-fc RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan
-
Bibeau F., Lopez-Crapez E., Fiore F. D., Thezenas S., Ychou M., Blanchard F., Lamy A., Penault-Llorca F., Frbourg T., Michel P., Sabourin J. C., Boissire-Michot F., Impact of fc RIIa-fc RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan Journal of Clinical Oncology 2009 27 7 1122 1129
-
(2009)
Journal of Clinical Oncology
, vol.27
, Issue.7
, pp. 1122-1129
-
-
Bibeau, F.1
Lopez-Crapez, E.2
Fiore, F.D.3
Thezenas, S.4
Ychou, M.5
Blanchard, F.6
Lamy, A.7
Penault-Llorca, F.8
Frbourg, T.9
Michel, P.10
Sabourin, J.C.11
Boissire-Michot, F.12
-
31
-
-
33748987908
-
Cancer despite immunosurveillance: Immunoselection and immunosubversion
-
DOI 10.1038/nri1936, PII NRI1936
-
Zitvogel L., Tesniere A., Kroemer G., Cancer despite immunosurveillance: immunoselection and immunosubversion Nature Reviews Immunology 2006 6 10 715 727 (Pubitemid 44453458)
-
(2006)
Nature Reviews Immunology
, vol.6
, Issue.10
, pp. 715-727
-
-
Zitvogel, L.1
Tesniere, A.2
Kroemer, G.3
-
32
-
-
0032529466
-
+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer
-
Naito Y., Saito K., Shiiba K., Ohuchi A., Saigenji K., Nagura H., Ohtani H., CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer Cancer Research 1998 58 16 3491 3494 (Pubitemid 28376536)
-
(1998)
Cancer Research
, vol.58
, Issue.16
, pp. 3491-3494
-
-
Naito, Y.1
Saito, K.2
Shiiba, K.3
Ohuchi, A.4
Saigenji, K.5
Nagura, H.6
Ohtani, H.7
-
33
-
-
29444442811
-
+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
-
DOI 10.1073/pnas.0509182102
-
Sato E., Olson S. H., Ahn J., Bundy B., Nishikawa H., Qian F., Jungbluth A. A., Frosina D., Gnjatic S., Ambrosone C., Kepner J., Odunsi T., Ritter G., Lele S., Chen Y. T., Ohtani H., Old L. J., Odunsi K., Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer Proceedings of the National Academy of Sciences of the United States of America 2005 102 51 18538 18543 (Pubitemid 43011261)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.51
, pp. 18538-18543
-
-
Sato, E.1
Olson, S.H.2
Ahn, J.3
Bundy, B.4
Nishikawa, H.5
Qian, F.6
Jungbluth, A.A.7
Frosina, D.8
Gnjatic, S.9
Ambrosone, C.10
Kepner, J.11
Odunsi, T.12
Ritter, G.13
Lele, S.14
Chen, Y.-T.15
Ohtani, H.16
Old, L.J.17
Odunsi, K.18
-
34
-
-
33749319703
-
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
-
DOI 10.1126/science.1129139
-
Galon J., Costes A., Sanchez-Cabo F., Kirilovsky A., Mlecnik B., Lagorce-Pags C., Tosolini M., Camus M., Berger A., Wind P., Zinzindohou F., Bruneval P., Cugnenc P. H., Trajanoski Z., Fridman W. H., Pags F., Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 2006 313 5795 1960 1964 (Pubitemid 44498003)
-
(2006)
Science
, vol.313
, Issue.5795
, pp. 1960-1964
-
-
Galon, J.1
Costes, A.2
Sanchez-Cabo, F.3
Kirilovsky, A.4
Mlecnik, B.5
Lagorce-Pages, C.6
Tosolini, M.7
Camus, M.8
Berger, A.9
Wind, P.10
Zinzindohoue, F.11
Bruneval, P.12
Cugnenc, P.-H.13
Trajanoski, Z.14
Fridman, W.-H.15
Pages, F.16
-
35
-
-
70450185055
-
Decrease in intrahepatic CD56 + lymphocytes in gastric and colorectal cancer patients with liver metastases
-
Gulubova M., Manolova I., Kyurkchiev D., Julianov A., Altunkova I., Decrease in intrahepatic CD56 + lymphocytes in gastric and colorectal cancer patients with liver metastases Acta Pathologica, Microbiologica et Immunologica 2009 117 12 870 879
-
(2009)
Acta Pathologica, Microbiologica et Immunologica
, vol.117
, Issue.12
, pp. 870-879
-
-
Gulubova, M.1
Manolova, I.2
Kyurkchiev, D.3
Julianov, A.4
Altunkova, I.5
-
36
-
-
39049139508
-
- cells and display an impaired capability to kill tumor cells
-
DOI 10.1002/cncr.23239
-
Carrega P., Morandi B., Costa R., Frumento G., Forte G., Altavilla G., Ratto G. B., Mingari M. C., Moretta L., Ferlazzo G., Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16- cells and display an impaired capability to kill tumor cells Cancer 2008 112 4 863 875 (Pubitemid 351240580)
-
(2008)
Cancer
, vol.112
, Issue.4
, pp. 863-875
-
-
Carrega, P.1
Morandi, B.2
Costa, R.3
Frumento, G.4
Forte, G.5
Altavilla, G.6
Ratto, G.B.7
Mingari, M.C.8
Moretta, L.9
Ferlazzo, G.10
-
37
-
-
67650472304
-
Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves -integrin-mediated interaction
-
Sconocchia G., Spagnoli G. C., Del Principe D., Ferrone S., Anselmi M., Wongsena W., Cervelli V., Schultz-Thater E., Wyler S., Carafa V., Moch H., Terracciano L., Tornillo L., Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves -integrin-mediated interaction Neoplasia 2009 11 7 662 671
-
(2009)
Neoplasia
, vol.11
, Issue.7
, pp. 662-671
-
-
Sconocchia, G.1
Spagnoli, G.C.2
Del Principe, D.3
Ferrone, S.4
Anselmi, M.5
Wongsena, W.6
Cervelli, V.7
Schultz-Thater, E.8
Wyler, S.9
Carafa, V.10
Moch, H.11
Terracciano, L.12
Tornillo, L.13
-
38
-
-
77954107953
-
Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells
-
Carlsten M., Norell H., Bryceson Y. T., Poschke I., Schedvins K., Ljunggren H. G., Kiessling R., Malmberg K. J., Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells Journal of Immunology 2009 183 8 4921 4930
-
(2009)
Journal of Immunology
, vol.183
, Issue.8
, pp. 4921-4930
-
-
Carlsten, M.1
Norell, H.2
Bryceson, Y.T.3
Poschke, I.4
Schedvins, K.5
Ljunggren, H.G.6
Kiessling, R.7
Malmberg, K.J.8
-
39
-
-
37049020929
-
Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer
-
DOI 10.1158/0008-5472.CAN-07-2637
-
Katou F., Ohtani H., Watanabe Y., Nakayama T., Yoshie O., Hashimoto K., Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer Cancer Research 2007 67 23 11195 11201 (Pubitemid 350248544)
-
(2007)
Cancer Research
, vol.67
, Issue.23
, pp. 11195-11201
-
-
Katou, F.1
Ohtani, H.2
Watanabe, Y.3
Nakayama, T.4
Yoshie, O.5
Hashimoto, K.6
-
40
-
-
77951042495
-
CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells
-
Baessler T., Charton J. E., Schmiedel B. J., Grnebach F., Krusch M., Wacker A., Rammensee H. G., Salih H. R., CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells Blood 2010 115 15 3058 3069
-
(2010)
Blood
, vol.115
, Issue.15
, pp. 3058-3069
-
-
Baessler, T.1
Charton, J.E.2
Schmiedel, B.J.3
Grnebach, F.4
Krusch, M.5
Wacker, A.6
Rammensee, H.G.7
Salih, H.R.8
-
41
-
-
68549125484
-
Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells
-
Konjevi G., Mirjai Martinovi K., Jurii V., Babovi N., Spui I., Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells Biomarkers 2009 14 4 258 270
-
(2009)
Biomarkers
, vol.14
, Issue.4
, pp. 258-270
-
-
Konjevi, G.1
Mirjai Martinovi, K.2
Jurii, V.3
Babovi, N.4
Spui, I.5
-
42
-
-
65949111524
-
Natural killer lysis receptor (NKLR)/NKLR-ligand matching as a novel approach for enhancing anti-tumor activity of allogeneic NK cells
-
Markel G., Seidman R., Besser M. J., Zabari N., Ortenberg R., Shapira R., Treves A. J., Loewenthal R., Orenstein A., Nagler A., Schachter J., Natural killer lysis receptor (NKLR)/NKLR-ligand matching as a novel approach for enhancing anti-tumor activity of allogeneic NK cells PLoS ONE 2009 4 5
-
(2009)
PLoS ONE
, vol.4
, Issue.5
-
-
Markel, G.1
Seidman, R.2
Besser, M.J.3
Zabari, N.4
Ortenberg, R.5
Shapira, R.6
Treves, A.J.7
Loewenthal, R.8
Orenstein, A.9
Nagler, A.10
Schachter, J.11
-
43
-
-
70350116692
-
Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors
-
Szczepanski M. J., Szajnik M., Welsh A., Foon K. A., Whiteside T. L., Boyiadzis M., Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors Cancer Immunology, Immunotherapy 2010 59 1 73 79
-
(2010)
Cancer Immunology, Immunotherapy
, vol.59
, Issue.1
, pp. 73-79
-
-
Szczepanski, M.J.1
Szajnik, M.2
Welsh, A.3
Foon, K.A.4
Whiteside, T.L.5
Boyiadzis, M.6
-
44
-
-
44449119045
-
Intracellular retention of the NKG2D ligand MHC class i chain-related gene a in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity
-
Fuertes M. B., Girart M. V., Molinero L. L., Domaica C. I., Rossi L. E., Barrio M. M., Mordoh J., Rabinovich G. A., Zwirner N. W., Intracellular retention of the NKG2D ligand MHC class i chain-related gene a in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity Journal of Immunology 2008 180 7 4606 4614
-
(2008)
Journal of Immunology
, vol.180
, Issue.7
, pp. 4606-4614
-
-
Fuertes, M.B.1
Girart, M.V.2
Molinero, L.L.3
Domaica, C.I.4
Rossi, L.E.5
Barrio, M.M.6
Mordoh, J.7
Rabinovich, G.A.8
Zwirner, N.W.9
-
45
-
-
0030848994
-
Signal transduction during natural killer cell activation: Inside the mind of a killer
-
DOI 10.1016/S1074-7613(00)80441-0
-
Leibson P. J., Signal transduction during natural killer cell activation: inside the mind of a killer Immunity 1997 6 6 655 661 (Pubitemid 27305728)
-
(1997)
Immunity
, vol.6
, Issue.6
, pp. 655-661
-
-
Leibson, P.J.1
-
46
-
-
42549149026
-
Potential role of NK cells in the induction of immune responses: Implications for NK cell-based immunotherapy for cancers and viral infections
-
DOI 10.1080/08830180801911743, PII 792567129
-
Terunuma H., Deng X., Dewan Z., Fujimoto S., Yamamoto N., Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections International Reviews of Immunology 2008 27 3 93 110 (Pubitemid 351589824)
-
(2008)
International Reviews of Immunology
, vol.27
, Issue.3
, pp. 93-110
-
-
Terunuma, H.1
Deng, X.2
Dewan, Z.3
Fujimoto, S.4
Yamamoto, N.5
-
47
-
-
33747101972
-
Human NK Cell Education by Inhibitory Receptors for MHC Class I
-
DOI 10.1016/j.immuni.2006.06.013, PII S1074761306003487
-
Anfossi N., Andr P., Guia S., Falk C. S., Roetynck S., Stewart C. A., Breso V., Frassati C., Reviron D., Middleton D., Romagn F., Ugolini S., Vivier E., Human NK cell education by inhibitory receptors for MHC class I Immunity 2006 25 2 331 342 (Pubitemid 44224147)
-
(2006)
Immunity
, vol.25
, Issue.2
, pp. 331-342
-
-
Anfossi, N.1
Andre, P.2
Guia, S.3
Falk, C.S.4
Roetynck, S.5
Stewart, C.A.6
Breso, V.7
Frassati, C.8
Reviron, D.9
Middleton, D.10
Romagne, F.11
Ugolini, S.12
Vivier, E.13
-
48
-
-
0034076307
-
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
-
DOI 10.1038/74704
-
Clynes R. A., Towers T. L., Presta L. G., Ravetch J. V., Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets Nature Medicine 2000 6 4 443 446 (Pubitemid 30208162)
-
(2000)
Nature Medicine
, vol.6
, Issue.4
, pp. 443-446
-
-
Clynes, R.A.1
Towers, T.L.2
Presta, L.G.3
Ravetch, J.V.4
-
49
-
-
54249100952
-
Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia
-
Horton H. M., Bernett M. J., Pong E., Peipp M., Karki S., Chu S. Y., Richards J. O., Vostiar I., Joyce P. F., Repp R., Desjarlais J. R., Zhukovsky E. A., Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia Cancer Research 2008 68 19 8049 8057
-
(2008)
Cancer Research
, vol.68
, Issue.19
, pp. 8049-8057
-
-
Horton, H.M.1
Bernett, M.J.2
Pong, E.3
Peipp, M.4
Karki, S.5
Chu, S.Y.6
Richards, J.O.7
Vostiar, I.8
Joyce, P.F.9
Repp, R.10
Desjarlais, J.R.11
Zhukovsky, E.A.12
-
50
-
-
65549147346
-
The impact of Fc engineering on an anti-CD19 antibody: Increased Fc receptor affinity enhances B-cell clearing in nonhuman primates
-
Zalevsky J., Leung I. W. L., Karki S., Chu S. Y., Zhukovsky E. A., Desjarlais J. R., Carmichael D. F., Lawrence C. E., The impact of Fc engineering on an anti-CD19 antibody: increased Fc receptor affinity enhances B-cell clearing in nonhuman primates Blood 2009 113 16 3735 3743
-
(2009)
Blood
, vol.113
, Issue.16
, pp. 3735-3743
-
-
Zalevsky, J.1
Leung, I.W.L.2
Karki, S.3
Chu, S.Y.4
Zhukovsky, E.A.5
Desjarlais, J.R.6
Carmichael, D.F.7
Lawrence, C.E.8
-
51
-
-
63349086603
-
Cetuximab-mediated cellular cytotoxicity is inhibited by HLA-E membrane expression in colon cancer cells
-
Levy E. M., Sycz G., Arriaga J. M., Barrio M. M., von Euw E. M., Morales S. B., Gonzlez M., Mordoh J., Bianchini M., Cetuximab-mediated cellular cytotoxicity is inhibited by HLA-E membrane expression in colon cancer cells Innate Immunity 2009 15 2 91 100
-
(2009)
Innate Immunity
, vol.15
, Issue.2
, pp. 91-100
-
-
Levy, E.M.1
Sycz, G.2
Arriaga, J.M.3
Barrio, M.M.4
Von Euw, E.M.5
Morales, S.B.6
Gonzlez, M.7
Mordoh, J.8
Bianchini, M.9
-
52
-
-
77952585049
-
Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC)
-
Correale P., Marra M., Remondo C., Migali C., Misso G., Arcuri F. P., Del Vecchio M. T., Carducci A., Loiacono L., Tassone P., Abbruzzese A., Tagliaferri P., Caraglia M., Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC) European Journal of Cancer 2010 46 9 1703 1711
-
(2010)
European Journal of Cancer
, vol.46
, Issue.9
, pp. 1703-1711
-
-
Correale, P.1
Marra, M.2
Remondo, C.3
Migali, C.4
Misso, G.5
Arcuri, F.P.6
Del Vecchio, M.T.7
Carducci, A.8
Loiacono, L.9
Tassone, P.10
Abbruzzese, A.11
Tagliaferri, P.12
Caraglia, M.13
-
53
-
-
73349142719
-
In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer
-
Pags F., Kirilovsky A., Mlecnik B., Asslaber M., Tosolini M., Bindea G., Lagorce C., Wind P., Marliot F., Bruneval P., Zatloukal K., Trajanoski Z., Berger A., Fridman W. H., Galon J., In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer Journal of Clinical Oncology 2009 27 35 5944 5951
-
(2009)
Journal of Clinical Oncology
, vol.27
, Issue.35
, pp. 5944-5951
-
-
Pags, F.1
Kirilovsky, A.2
Mlecnik, B.3
Asslaber, M.4
Tosolini, M.5
Bindea, G.6
Lagorce, C.7
Wind, P.8
Marliot, F.9
Bruneval, P.10
Zatloukal, K.11
Trajanoski, Z.12
Berger, A.13
Fridman, W.H.14
Galon, J.15
-
54
-
-
68549117138
-
Decreased levels of circulating regulatory NK cells in patients with head and neck cancer throughout all tumor stages
-
Wulff S., Pries R., Brngen K., Trenkle T., Wollenberg B., Decreased levels of circulating regulatory NK cells in patients with head and neck cancer throughout all tumor stages Anticancer Research 2009 29 8 3053 3057
-
(2009)
Anticancer Research
, vol.29
, Issue.8
, pp. 3053-3057
-
-
Wulff, S.1
Pries, R.2
Brngen, K.3
Trenkle, T.4
Wollenberg, B.5
-
55
-
-
76349088256
-
Interleukin-21 can efficiently restore impaired antibody-dependent cell-mediated cytotoxicity in patients with oesophageal squamous cell carcinoma
-
Watanabe M., Kono K., Kawaguchi Y., Mizukami Y., Mimura K., Maruyama T., Fujii H., Interleukin-21 can efficiently restore impaired antibody-dependent cell-mediated cytotoxicity in patients with oesophageal squamous cell carcinoma British Journal of Cancer 2010 102 3 520 529
-
(2010)
British Journal of Cancer
, vol.102
, Issue.3
, pp. 520-529
-
-
Watanabe, M.1
Kono, K.2
Kawaguchi, Y.3
Mizukami, Y.4
Mimura, K.5
Maruyama, T.6
Fujii, H.7
-
56
-
-
61449202998
-
The clinical benefit of bevacizumab in metastatic colorectal cancer is independent of K-ras mutation status: Analysis of a phase in study of bevacizumab with chemotherapy in previously untreated metastatic colorectal cancer
-
Hurwitz H. I., Yi J., Ince W., Novotny W. F., Rosen O., The clinical benefit of bevacizumab in metastatic colorectal cancer is independent of K-ras mutation status: analysis of a phase in study of bevacizumab with chemotherapy in previously untreated metastatic colorectal cancer Oncologist 2009 14 1 22 28
-
(2009)
Oncologist
, vol.14
, Issue.1
, pp. 22-28
-
-
Hurwitz, H.I.1
Yi, J.2
Ince, W.3
Novotny, W.F.4
Rosen, O.5
-
57
-
-
51649123319
-
Lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells
-
Wu L., Adams M., Carter T., Chen R., Muller G., Stirling D., Schafer P., Bartlett J. B., Lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells Clinical Cancer Research 2008 14 14 4650 4657
-
(2008)
Clinical Cancer Research
, vol.14
, Issue.14
, pp. 4650-4657
-
-
Wu, L.1
Adams, M.2
Carter, T.3
Chen, R.4
Muller, G.5
Stirling, D.6
Schafer, P.7
Bartlett, J.B.8
-
58
-
-
79953744107
-
Lenalidomide enhances antibody-dependent cellular cytotoxicity of solid tumor cells in vitro: Influence of host immune and tumor markers
-
Wu L., Parton A., Lu L., Adams M., Schafer P., Bartlett J. B., Lenalidomide enhances antibody-dependent cellular cytotoxicity of solid tumor cells in vitro: influence of host immune and tumor markers Cancer Immunology, Immunotherapy 2011 60 1 61 73
-
(2011)
Cancer Immunology, Immunotherapy
, vol.60
, Issue.1
, pp. 61-73
-
-
Wu, L.1
Parton, A.2
Lu, L.3
Adams, M.4
Schafer, P.5
Bartlett, J.B.6
-
59
-
-
78049477140
-
Lenalidomide in nonmetastatic biochemically relapsed prostate cancer: Results of a phase I/II double-blinded, randomized study
-
Keizman D., Zahurak M., Sinibaldi V., Carducci M., Denmeade S., Drake C., Pili R., Antonarakis E. S., Hudock S., Eisenberger M., Lenalidomide in nonmetastatic biochemically relapsed prostate cancer: results of a phase I/II double-blinded, randomized study Clinical Cancer Research 2010 16 21 5269 5276
-
(2010)
Clinical Cancer Research
, vol.16
, Issue.21
, pp. 5269-5276
-
-
Keizman, D.1
Zahurak, M.2
Sinibaldi, V.3
Carducci, M.4
Denmeade, S.5
Drake, C.6
Pili, R.7
Antonarakis, E.S.8
Hudock, S.9
Eisenberger, M.10
-
60
-
-
33846564399
-
Cetuximab induce antibody-dependent cellular cytotoxicity against EGFR-expressing esophageal squamous cell carcinoma
-
DOI 10.1002/ijc.22370
-
Kawaguchi Y., Kono K., Mimura K., Sugai H., Akaike H., Fujii H., Cetuximab induce antibody-dependent cellular cytotoxicity against EGFR-expressing esophageal squamous cell carcinoma International Journal of Cancer 2007 120 4 781 787 (Pubitemid 46175397)
-
(2007)
International Journal of Cancer
, vol.120
, Issue.4
, pp. 781-787
-
-
Kawaguchi, Y.1
Kono, K.2
Mimura, K.3
Sugai, H.4
Akaike, H.5
Fujii, H.6
-
61
-
-
78649515791
-
NK cell dysfunction with down-regulated CD16 and up-regulated CD56 molecules in patients with esophageal squamous cell carcinoma
-
Watanabe M., Kono K., Kawaguchi Y., Mizukami Y., Mimura K., Maruyama T., Izawa S., Fujii H., NK cell dysfunction with down-regulated CD16 and up-regulated CD56 molecules in patients with esophageal squamous cell carcinoma Diseases of the Esophagus 2010 23 8 675 681
-
(2010)
Diseases of the Esophagus
, vol.23
, Issue.8
, pp. 675-681
-
-
Watanabe, M.1
Kono, K.2
Kawaguchi, Y.3
Mizukami, Y.4
Mimura, K.5
Maruyama, T.6
Izawa, S.7
Fujii, H.8
-
62
-
-
35948961556
-
The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor - Positive tumor cells is enhanced by cytokines
-
DOI 10.1158/1078-0432.CCR-07-0865
-
Roda J. M., Joshi T., Butchar J. P., McAlees J. W., Lehman A., Tridandapani S., Carson W. E., The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptorpositive tumor cells is enhanced by cytokines Clinical Cancer Research 2007 13 21 6419 6428 (Pubitemid 350075032)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.21
, pp. 6419-6428
-
-
Roda, J.M.1
Joshi, T.2
Butchar, J.P.3
McAlees, J.W.4
Lehman, A.5
Tridandapani, S.6
Carson III, W.E.7
-
63
-
-
33947420511
-
Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell lines
-
DOI 10.1158/1078-0432.CCR-06-1726
-
Kurai J., Chikumi H., Hashimoto K., Yamaguchi K., Yamasaki A., Sako T., Touge H., Makino H., Takata M., Miyata M., Nakamoto M., Burioka N., Shimizu E., Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell lines Clinical Cancer Research 2007 13 5 1552 1561 (Pubitemid 46450447)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.5
, pp. 1552-1561
-
-
Kurai, J.1
Chikumi, H.2
Hashimoto, K.3
Yamaguchi, K.4
Yamasaki, A.5
Sako, T.6
Touge, H.7
Makino, H.8
Takata, M.9
Miyata, M.10
Nakamoto, M.11
Burioka, N.12
Shimizu, E.13
-
64
-
-
44449108782
-
Interleukin-2 potentiation of cetuximab antitumor activity for epidermal growth factor receptor-overexpressing gastric cancer xenografts through antibody-dependent cellular cytotoxicity
-
DOI 10.1111/j.1349-7006.2008.00821.x
-
Hara M., Nakanishi H., Tsujimura K., Matsui M., Yatabe Y., Manabe T., Tatematsu M., Interleukin-2 potentiation of cetuximab antitumor activity for epidermal growth factor receptor-overexpressing gastric cancer xenografts through antibody-dependent cellular cytotoxicity Cancer Science 2008 99 7 1471 1478 (Pubitemid 351761740)
-
(2008)
Cancer Science
, vol.99
, Issue.7
, pp. 1471-1478
-
-
Hara, M.1
Nakanishi, H.2
Tsujimura, K.3
Matsui, M.4
Yatabe, Y.5
Manabe, T.6
Tatematsu, M.7
-
65
-
-
0037108686
-
Impaired antibody-dependent cellular cytotoxicity mediated by Herceptin in patients with gastric cancer
-
Kono K., Takahashi A., Ichihara F., Sugai H., Fujii H., Matsumoto Y., Impaired antibody-dependent cellular cytotoxicity mediated by Herceptin in patients with gastric cancer Cancer Research 2002 62 20 5813 5817 (Pubitemid 35204740)
-
(2002)
Cancer Research
, vol.62
, Issue.20
, pp. 5813-5817
-
-
Kono, K.1
Takahashi, A.2
Ichihara, F.3
Sugai, H.4
Fujii, H.5
Matsumoto, Y.6
-
66
-
-
79959355065
-
-
Breast Cancer Research and Treatment. In press
-
Roberti M. P., Barrio M. M., Bravo A. I., Rocca Y. S., Arriaga J. M., Bianchini M., Mordoh J., Levy E. M., IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR. Breast Cancer Research and Treatment. In press
-
IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR
-
-
Roberti, M.P.1
Barrio, M.M.2
Bravo, A.I.3
Rocca, Y.S.4
Arriaga, J.M.5
Bianchini, M.6
Mordoh, J.7
Levy, E.M.8
-
67
-
-
0037174674
-
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
-
DOI 10.1126/science.1076514
-
Dudley M. E., Wunderlich J. R., Robbins P. F., Yang J. C., Hwu P., Schwartzentruber D. J., Topalian S. L., Sherry R., Restifo N. P., Hubicki A. M., Robinson M. R., Raffeld M., Duray P., Seipp C. A., Rogers-Freezer L., Morton K. E., Mavroukakis S. A., White D. E., Rosenberg S. A., Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes Science 2002 298 5594 850 854 (Pubitemid 35231542)
-
(2002)
Science
, vol.298
, Issue.5594
, pp. 850-854
-
-
Dudley, M.E.1
Wunderlich, J.R.2
Robbins, P.F.3
Yang, J.C.4
Hwu, P.5
Schwartzentruber, D.J.6
Topalian, S.L.7
Sherry, R.8
Restifo, N.P.9
Hubicki, A.M.10
Robinson, M.R.11
Raffeld, M.12
Duray, P.13
Seipp, C.A.14
Rogers-Freezer, L.15
Morton, K.E.16
Mavroukakis, S.A.17
White, D.E.18
Rosenberg, S.A.19
-
68
-
-
33847056957
-
Good manufacturing practices production of natural killer cells for immunotherapy: A six-year single-institution experience
-
McKenna D. H., Sumstad D., Bostrom N., Kadidlo D. M., Fautsch S., McNearney S., DeWaard R., McGlave P. B., Weisdorf D. J., Wagner J. E., McCullough J., Miller J. S., Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience Transfusion 2007 47 3 520 528
-
(2007)
Transfusion
, vol.47
, Issue.3
, pp. 520-528
-
-
McKenna, D.H.1
Sumstad, D.2
Bostrom, N.3
Kadidlo, D.M.4
Fautsch, S.5
McNearney, S.6
Dewaard, R.7
McGlave, P.B.8
Weisdorf, D.J.9
Wagner, J.E.10
McCullough, J.11
Miller, J.S.12
-
69
-
-
77950149420
-
High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy
-
Spanholtz J., Tordoir M., Eissens D., Preijers F., Van Meer Der A., Joosten I., Schaap N., De Witte T. M., Dolstra H., High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy PLoS ONE 2010 5 2
-
(2010)
PLoS ONE
, vol.5
, Issue.2
-
-
Spanholtz, J.1
Tordoir, M.2
Eissens, D.3
Preijers, F.4
Van Meer Der, A.5
Joosten, I.6
Schaap, N.7
De Witte, T.M.8
Dolstra, H.9
-
70
-
-
78649303217
-
Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor
-
Sutlu T., Stellan B., Gilljam M., Quezada H. C., Nahi H., Gahrton G., Alici E., Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor Cytotherapy 2010 12 8 1044 1055
-
(2010)
Cytotherapy
, vol.12
, Issue.8
, pp. 1044-1055
-
-
Sutlu, T.1
Stellan, B.2
Gilljam, M.3
Quezada, H.C.4
Nahi, H.5
Gahrton, G.6
Alici, E.7
-
71
-
-
0029143210
-
Natural killer cell receptors: The offs and ons of NK cell recognition
-
Raulet D. H., Held W., Natural killer cell receptors: the offs and ons of NK cell recognition Cell 1995 82 5 697 700
-
(1995)
Cell
, vol.82
, Issue.5
, pp. 697-700
-
-
Raulet, D.H.1
Held, W.2
-
72
-
-
0028912215
-
Express yourself or die: Peptides, MHC molecules, and NK cells
-
Karre K., Express yourself or die: peptides, MHC molecules, and NK cells Science 1995 267 5200 978 979
-
(1995)
Science
, vol.267
, Issue.5200
, pp. 978-979
-
-
Karre, K.1
-
73
-
-
0027284452
-
P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities
-
Moretta A., Vitale M., Bottino C., Orengo A. M., Morelli L., Augugliaro R., Barbaresi M., Ciccone E., Moretta L., P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities Journal of Experimental Medicine 1993 178 2 597 604 (Pubitemid 23218208)
-
(1993)
Journal of Experimental Medicine
, vol.178
, Issue.2
, pp. 597-604
-
-
Moretta, A.1
Vitale, M.2
Bottino, C.3
Orengo, A.M.4
Morelli, L.5
Augugliaro, R.6
Barbaresi, M.7
Ciccone, E.8
Moretta, L.9
-
74
-
-
0037086131
-
Effectiveness of donor natural killer cell aloreactivity in mismatched hematopoietic transplants
-
DOI 10.1126/science.1068440
-
Ruggeri L., Capanni M., Urbani E., Perruccio K., Shlomchik W. D., Tosti A., Posati S., Rogaia D., Frassoni F., Aversa F., Martelli M. F., Velardi A., Effectiveness of donor natural killer cell aloreactivity in mismatched hematopoietic transplants Science 2002 295 5562 2097 2100 (Pubitemid 34229476)
-
(2002)
Science
, vol.295
, Issue.5562
, pp. 2097-2100
-
-
Ruggeri, L.1
Capanni, M.2
Urbani, E.3
Perruccio, K.4
Shlomchik, W.D.5
Tosti, A.6
Posati, S.7
Rogaia, D.8
Frassoni, F.9
Aversa, F.10
Martelli, M.F.11
Velardi, A.12
-
75
-
-
17444428649
-
Natural killer cell receptors: Regulating innate immune responses to hematologic malignancy
-
DOI 10.1053/j.seminhematol.2005.01.010
-
Hsu K. C., Dupont B. O., Natural killer cell receptors: regulating innate immune responses to hematologic malignancy Seminars in Hematology 2005 42 2 91 103 (Pubitemid 40544299)
-
(2005)
Seminars in Hematology
, vol.42
, Issue.2
, pp. 91-103
-
-
Hsu, K.C.1
Dupont, B.2
-
76
-
-
20544470873
-
The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation
-
DOI 10.1016/j.trim.2005.03.008, PII S0966327405000377
-
Ruggeri L., Capanni M., Mancusi A., Martelli M. F., Velardi A., The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation Transplant Immunology 2005 14 3-4 203 206 (Pubitemid 40848526)
-
(2005)
Transplant Immunology
, vol.14
, Issue.3 SPEC. ISS.
, pp. 203-206
-
-
Ruggeri, L.1
Capanni, M.2
Mancusi, A.3
Martelli, M.F.4
Velardi, A.5
-
77
-
-
34250006553
-
Intensity of HLA class I expression and KIR-mismatch determine NK-cell mediated lysis of leukaemic blasts from children with acute lymphatic leukaemia
-
DOI 10.1111/j.1365-2141.2007.06631.x
-
Pfeiffer M., Schumm M., Feuchtinger T., Dietz K., Handgretinger R., Lang P., Intensity of HLA class I expression and KIR-mismatch determine NK-cell mediated lysis of leukaemic blasts from children with acute lymphatic leukaemia British Journal of Haematology 2007 138 1 97 100 (Pubitemid 46889794)
-
(2007)
British Journal of Haematology
, vol.138
, Issue.1
, pp. 97-100
-
-
Pfeiffer, M.1
Schumm, M.2
Feuchtinger, T.3
Dietz, K.4
Handgretinger, R.5
Lang, P.6
-
78
-
-
38449091911
-
Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands
-
Yu J., Heller G., Chewning J., Kim S., Yokoyama W. M., Hsu K. C., Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands Journal of Immunology 2007 179 9 5977 5989
-
(2007)
Journal of Immunology
, vol.179
, Issue.9
, pp. 5977-5989
-
-
Yu, J.1
Heller, G.2
Chewning, J.3
Kim, S.4
Yokoyama, W.M.5
Hsu, K.C.6
-
79
-
-
10744230735
-
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors
-
DOI 10.1182/blood-2003-01-0091
-
Giebel S., Locatelli F., Lamparelli T., Velardi A., Davies S., Frumento G., Maccario R., Bonetti F., Wojnar J., Martinetti M., Frassoni F., Giorgiani G., Bacigalupo A., Holowiecki J., Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors Blood 2003 102 3 814 819 (Pubitemid 36917769)
-
(2003)
Blood
, vol.102
, Issue.3
, pp. 814-819
-
-
Giebel, S.1
Locatelli, F.2
Lamparelli, T.3
Velardi, A.4
Davies, S.5
Frumento, G.6
Maccario, R.7
Bonetti, F.8
Wojnar, J.9
Martinetti, M.10
Frassoni, F.11
Giorgiani, G.12
Bacigalupo, A.13
Holowiecki, J.14
-
80
-
-
17844392065
-
Natural killer cell alloreactivity for leukemia therapy
-
Ruggeri L., Mancusi A., Perruccio K., Burchielli E., Martelli M. F., Velardi A., Natural killer cell alloreactivity for leukemia therapy Journal of Immunotherapy 2005 28 3 175 182 (Pubitemid 40593982)
-
(2005)
Journal of Immunotherapy
, vol.28
, Issue.3
, pp. 175-182
-
-
Ruggeri, L.1
Mancusi, A.2
Perruccio, K.3
Burchielli, E.4
Martelli, M.F.5
Velardi, A.6
-
81
-
-
15244346488
-
Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias
-
DOI 10.1182/blood-2004-04-1441
-
Beelen D. W., Ottinger H. D., Ferencik S., Elmaagacli A. H., Peceny R., Trenschel R., Grosse-Wilde H., Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias Blood 2005 105 6 2594 2600 (Pubitemid 40387064)
-
(2005)
Blood
, vol.105
, Issue.6
, pp. 2594-2600
-
-
Beelen, D.W.1
Ottinger, H.D.2
Ferencik, S.3
Elmaagacli, A.H.4
Peceny, R.5
Trenschel, R.6
Grosse-Wilde, H.7
-
82
-
-
63849288804
-
HLA mismatch combinations associated with decreased risk of relapse: Implications for the molecular mechanism
-
Kawase T., Matsuo K., Kashiwase K., Inoko H., Saji H., Ogawa S., Kato S., Sasazuki T., Kodera Y., Morishima Y., HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism Blood 2009 113 12 2851 2858
-
(2009)
Blood
, vol.113
, Issue.12
, pp. 2851-2858
-
-
Kawase, T.1
Matsuo, K.2
Kashiwase, K.3
Inoko, H.4
Saji, H.5
Ogawa, S.6
Kato, S.7
Sasazuki, T.8
Kodera, Y.9
Morishima, Y.10
-
83
-
-
77955119958
-
Cytotoxicity of activated natural killer cells against pediatric solid tumors
-
Cho D., Shook D. R., Shimasaki N., Chang Y.-H., Fujisaki H., Campana D., Cytotoxicity of activated natural killer cells against pediatric solid tumors Clinical Cancer Research 2010 16 15 3901 3909
-
(2010)
Clinical Cancer Research
, vol.16
, Issue.15
, pp. 3901-3909
-
-
Cho, D.1
Shook, D.R.2
Shimasaki, N.3
Chang, Y.-H.4
Fujisaki, H.5
Campana, D.6
-
84
-
-
53749088229
-
Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: A phase i trial
-
Arai S., Meagher R., Swearingen M., Myint H., Rich E., Martinson J., Klingemann H., Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial Cytotherapy 2008 10 6 625 632
-
(2008)
Cytotherapy
, vol.10
, Issue.6
, pp. 625-632
-
-
Arai, S.1
Meagher, R.2
Swearingen, M.3
Myint, H.4
Rich, E.5
Martinson, J.6
Klingemann, H.7
-
85
-
-
77957661092
-
A phase i trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
-
Iliopoulou E. G., Kountourakis P., Karamouzis M. V., Doufexis D., Ardavanis A., Baxevanis C. N., Rigatos G., Papamichail M., Perez S. A., A phase i trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer Cancer Immunology, Immunotherapy 2010 59 12 1781 1789
-
(2010)
Cancer Immunology, Immunotherapy
, vol.59
, Issue.12
, pp. 1781-1789
-
-
Iliopoulou, E.G.1
Kountourakis, P.2
Karamouzis, M.V.3
Doufexis, D.4
Ardavanis, A.5
Baxevanis, C.N.6
Rigatos, G.7
Papamichail, M.8
Perez, S.A.9
-
86
-
-
78650400901
-
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
-
Geller M. A., Cooley S., Judson P. L., Ghebre R., Carson L. F., Argenta P. A., Jonson A. L., Panoskaltsis-Mortari A., Curtsinger J., McKenna D., Dusenbery K., Bliss R., Downs L. S., Miller J. S., A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer Cytotherapy 2010 13 1 98 107
-
(2010)
Cytotherapy
, vol.13
, Issue.1
, pp. 98-107
-
-
Geller, M.A.1
Cooley, S.2
Judson, P.L.3
Ghebre, R.4
Carson, L.F.5
Argenta, P.A.6
Jonson, A.L.7
Panoskaltsis-Mortari, A.8
Curtsinger, J.9
McKenna, D.10
Dusenbery, K.11
Bliss, R.12
Downs, L.S.13
Miller, J.S.14
-
87
-
-
77953404092
-
Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: A Phase i clinical study
-
Barkholt L., Alici E., Conrad R., Sutlu T., Gilljam M., Birgitta-Stellan., Christensson B., Guven H., Bjrkstrm N. K., Sderdahl G., Cederlund K., Kimby E., Aschan J., Ringdn O., Ljunggren H. G., Sirac-Dilber M., Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study Immunotherapy 2009 1 5 753 764
-
(2009)
Immunotherapy
, vol.1
, Issue.5
, pp. 753-764
-
-
Barkholt, L.1
Alici, E.2
Conrad, R.3
Sutlu, T.4
Gilljam, M.5
Birgitta-Stellan6
Christensson, B.7
Guven, H.8
Bjrkstrm, N.K.9
Sderdahl, G.10
Cederlund, K.11
Kimby, E.12
Aschan, J.13
Ringdn, O.14
Ljunggren, H.G.15
Sirac-Dilber, M.16
-
88
-
-
77951499495
-
Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: Comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression
-
Decot V., Voillard L., Latger-Cannard V., Aissi-Roth L., Perrier P., Stoltz J. F., Bensoussan D., Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression Experimental Hematology 2010 38 5 351 362
-
(2010)
Experimental Hematology
, vol.38
, Issue.5
, pp. 351-362
-
-
Decot, V.1
Voillard, L.2
Latger-Cannard, V.3
Aissi-Roth, L.4
Perrier, P.5
Stoltz, J.F.6
Bensoussan, D.7
-
89
-
-
0031015677
-
Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation
-
DOI 10.1007/s002770050246
-
Jiang Y. Z., Barrett A. J., Goldman J. M., Mavroudis D. A., Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation Annals of Hematology 1997 74 1 1 6 (Pubitemid 27050901)
-
(1997)
Annals of Hematology
, vol.74
, Issue.1
, pp. 1-6
-
-
Jiang, Y.Z.1
Barrett, A.J.2
Goldman, J.M.3
Mavroudis, D.A.4
|